NCT06714864View on ClinicalTrials.gov

Open-Label Study to Assess Safety and Time to Catheter-related Bloodstream Infections (CRBSI) in Subjects From Birth to < 18 Years of Age

PHASE4RecruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 8, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

March 31, 2026

Conditions
Catheter-Related Infections
Interventions
DRUG

(taurolidine and heparin) catheter lock solution

for central venous catheter instillation use

DRUG

Standard of Care

Site specific standard of care

Trial Locations (3)

19803

RECRUITING

Nemours Children's Hospital - DE, Wilmington

35233

RECRUITING

Children's of Alabama/University of Alabama, Birmingham

94304

RECRUITING

Stanford, Palo Alto

Sponsors

Lead Sponsor

CorMedix
All Listed Sponsors
lead

CorMedix

INDUSTRY

NCT06714864 - Open-Label Study to Assess Safety and Time to Catheter-related Bloodstream Infections (CRBSI) in Subjects From Birth to < 18 Years of Age | Biotech Hunter | Biotech Hunter